We came across a bullish thesis on CRISPR Therapeutics AG (CRSP) on Two Natural Cap’s Substack. In this article, we will ...

In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $46.78, marking a +2.7% move from the previous day.

In a step toward treating mitochondrial diseases, researchers in the Netherlands have successfully edited harmful mutations ...

In a step toward treating mitochondrial diseases, researchers in the Netherlands have successfully edited harmful mutations in mitochondrial DNA using a genetic tool known as a base editor.

Right or wrong, we still believe that we live in a world where traditional HPC simulation and modeling at high precision ...

This might help: The analyst community's current consensus price target of $77.21 is about 75% above this stock's present price. Finally, add Confluent ( CFLT -0.13%) to your list of the best stocks ...

We're a step closer to two men being able to have genetic children of their own after the creation of fertile mice by putting ...

Zebrafish have the remarkable and rare ability to regrow and repair their hearts after damage. New research from Caltech and ...

Technological advances in the design and delivery of mRNA have catalysed the rapid development of mRNA COVID-19 vaccines by ...

Radheshyam Kumawat India is increasingly being recognized as a global leader in today’s world, a recognition that stems from ...

Scientists at Fox Chase Cancer Center have identified a mutation in a common oncogene—a gene that can cause cancer—that may ...

Cells depend on the precise reading of DNA sequences to function correctly. This process, known as gene expression, ...